Related Experiment Video
Updated: Aug 17, 2026

Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method
Published on: April 18, 2019
Need for "counter-detailing" antibiotics
Abstract:
Selected antibiotic advertisements in medical journals are discussed to illustrate the misleading information that is often disseminated to physicians by the pharmaceutical industry. Laboratory and clinical data are presented to question the validity of selected advertisements which (1) encourage the use of Keflex for severe respiratory infections in children, (2) recommend the use of Keflex for the treatment of bacterial bronchitis, (3) suggest that high tissue penetration is a unique property of Vibramycin, (4) present pooled susceptability data which do not reflect microbial resistance patterns in the patient's hospital, (5) recommend twice-daily administration of Ancef for urinary tract infections but do not clearly state the potential danger of this regimen for other infections, (6) suggest that gentamicin should be given to adults in only two dosage sizes for the treatment of serious Gram-negative infections, and (7) lead the reader to assume that only women need to be treated for Trichomonas infections. It is suggested that as antibiotics are marketed, hospital therapeutics committees should evaluate their advantages and permit formulary additions for only those agents demonstrating increased efficacy, decreased toxicity or decreased cost. Pharmacists who monitor drug therapy can provide information to the physician which will increase his awareness of optimal antibiotic therapy.
Insights
Pharmaceutical advertising in medical journals often misleads physicians about antibiotic efficacy and usage. Evaluating drug claims and monitoring therapy are crucial for optimal antibiotic selection and patient safety.
Area of Science:
- Pharmacology
- Medical Marketing
- Infectious Diseases
Background:
- Antibiotic advertisements in medical journals are a primary source of information for physicians.
- The pharmaceutical industry disseminates information that may not always be accurate or complete.
- Physicians rely on this information for prescribing decisions, impacting patient care.
Purpose of the Study:
- To critically evaluate selected antibiotic advertisements for misleading information.
- To question the validity of specific claims made in pharmaceutical marketing.
- To advocate for improved drug information dissemination and physician awareness.
Main Methods:
- Analysis of selected antibiotic advertisements in medical journals.
- Review of laboratory and clinical data to assess advertisement claims.
- Identification of specific examples of potentially misleading information.
Main Results:
- Advertisements for Keflex, Vibramycin, Ancef, and gentamicin were found to contain questionable claims regarding efficacy, tissue penetration, dosage, and administration.
- Pooled susceptibility data presented in advertisements may not reflect local microbial resistance patterns.
- Some advertisements omit crucial information about potential dangers or target patient populations (e.g., Trichomonas treatment).
Conclusions:
- Hospital therapeutics committees should rigorously evaluate new antibiotic marketing claims.
- Formulary additions should prioritize antibiotics with proven efficacy, safety, and cost-effectiveness.
- Pharmacists play a vital role in educating physicians about optimal antibiotic therapy and monitoring drug use.
Related Concept Videos
Antibiotic Selection
Hand hygiene
Hand washing...
Differential Staining Technique
Microbiota Modulation by Antibiotics
Mechanism of Antibiotic Resistance in MRSA
Clinical Significance of Antibiotic Resistance

